Cardio Diagnostics Holdings, Inc. (CDIO): Submission of Matters to a Vote of Security Holders

Cardio Diagnostics Holdings, Inc. (CDIO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On September 18, 2026, Cardio Diagnostics Holdings, Inc., a Delaware corporation (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). Of the Company’s 2,959,469 shares of common stock issue

Event · Shareholder vote
Original reporting
Published Sep 18, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CDIO
Bearish
high confidence
Mentioned
$CDIO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CDIOBearishLow
01

Why it matters

The disclosure is routine corporate governance information with no immediate financial impact.

02

Market read

Low relevance for traders; primarily a compliance filing.

03

What to watch

Potential future dilution from the approved share‑issuance, but not material at this stage.

Relevance 6/10Novelty 2/10Timing: after annual meeting

Background

Cardio Diagnostics Holdings filed a Form 8‑K detailing the results of its annual shareholder meeting, including director elections and approval of a share‑issuance plan.

Company-level read

Ticker impact

$CDIOBearishHigh confidence
Context

SEC 8‑K filing reports the annual shareholder meeting vote results and approval of a share‑issuance proposal.

Expected impact

minimal to none

Evidence & confidence

The filing contains only vote tallies and approval of a non‑public financing plan, which typically does not move the stock.

Market effects

None; governance update only.

None

None

Counterpoint

No contrarian angle; the filing is purely informational.

Key entities

  • Cardio Diagnostics Holdings, Inc.

    Medical diagnostics company listed on NASDAQ under CDIO.

Related articles

$BALYMedAI 8/10

BALLY’S CORPORATION SECURES $560 MILLION OF ADDITIONAL FINANCING Proceeds to be Used to Repay Outstanding Debt, for General Corporate Purposes and to Fund…

Bally's Corp (BALY) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 BALLY’S CORPORATION SECURES $560 MILLION OF ADDITIONAL FINANCING Proceeds to be Used to Repay Outstanding Debt, for General Corporate Purposes and to Fund Additional Development of Bally’s Chicago PROVIDENCE, R.I., November 17, 2026 — Bally’s Corporation (NYSE: BALY)

$ITGRMed

Integer noteholders receive conversion terms following merger

Integer Holdings Corporation completed its merger with Armstrong Bidco Inc., triggering conversion rights for holders of its 2.125% Convertible Senior Notes due 2028 and 1.875% Convertible Senior Notes due 2030. Noteholders can convert their securities until January 8, 2027, receiving enhanced rates during the make-whole period. The company is not required to repurchase the notes due to the merger's cash-only nature.

$CNTYMed

Century Casinos, Inc. Announces Restatement of Previously Issued Financial Statements and Preliminary Third Quarter 2026 Financial Results

Century Casinos (CNTY) will restate financial statements due to accounting errors related to a minority interest in the Nugget Casino Resort. Preliminary Q3 2026 results show $60.2M in cash, $158.4M in revenue, and $20.7M in earnings. The company also announced the sale of its Canadian operations. The restatement may affect internal controls and financial reporting.